Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
UBS
Healthtrust
Cipla
Teva
Harvard Business School
Covington
Queensland Health
Moodys

Generated: April 20, 2018

DrugPatentWatch Database Preview

VANCENASE AQ Drug Profile

« Back to Dashboard

Which patents cover Vancenase Aq, and what generic alternatives are available?

Vancenase Aq is a drug marketed by Schering and is included in two NDAs.

The generic ingredient in VANCENASE AQ is beclomethasone dipropionate monohydrate. There are twenty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the beclomethasone dipropionate monohydrate profile page.
Summary for VANCENASE AQ
Drug patent expirations by year for VANCENASE AQ
Synonyms for VANCENASE AQ
(11beta,16beta)-9-chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
(1R,2S,10S,11S,13S,14R,15S,17S)-1-CHLORO-14,17-DIHYDROXY-14-(2-HYDROXYACETYL)-2,13,15-TRIMETHYLTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-5-ONE
(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloranyl-10,13,16-trimethyl-11,17-bis(oxidanyl)-17-(2-oxidanylethanoyl)-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-17-glycoloyl-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
179957-EP2272832A1
20528-EP2295402A2
20528-EP2295409A1
20528-EP2314585A1
20528-EP2314590A1
4419-39-0
8060AH
9-Chloro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione
9-Chloro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione (Beclometasone)
9alpha-Chloro-11beta,17alpha,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione
9alpha-Chloro-16beta-methylprednisolone
AC1L2GBM
API0001600
BCBcMAP01_000159
BDBM53488
Beclocort
Beclometason (TN)
Beclometasona
Beclometasona [INN-Spanish]
Beclometasondipropionat Mikron
Beclometasone
Beclometasone (INN)
Beclometasone [INN:BAN]
Beclometasone [INN]
Beclometasonum
Beclometasonum [INN-Latin]
beclomethasone
Beconasol
BIDD:GT0556
BMJ 5800
C06842
C22H29ClO5
CAS-4419-39-0
CHEBI:3001
CHEMBL1586
cid_20469
CS-5872
D07495
DSSTox_CID_20750
DSSTox_GSID_40750
DSSTox_RID_79587
DTXSID5040750
EINECS 224-585-9
FT-0662507
GTPL7059
HMS2233A18
HY-B1540
Inalone
KGZ1SLC28Z
LS-174992
MFCD00135614
MLS000028668
MLS001076089
MolPort-003-844-701
NBMKJKDGKREAPL-DVTGEIKXSA-N
NCGC00164402-01
NCGC00179392-03
Opera_ID_1081
PL001805
Pregna-1,4-diene-3,20-dione, 9-chloro-11,17,21-trihydroxy-16-methyl-, (11beta,16beta)-
pulvinal
SC-65670
SCHEMBL3183
SMP1_000039
SMR000058899
SR-01000000273
SR-01000000273-4
Tox21_112116
Tox21_112116_1
UNII-KGZ1SLC28Z
ZINC4097285

US Patents and Regulatory Information for VANCENASE AQ

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering VANCENASE AQ beclomethasone dipropionate monohydrate SPRAY, METERED;NASAL 019589-001 Dec 23, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Schering VANCENASE AQ beclomethasone dipropionate monohydrate SPRAY, METERED;NASAL 020469-001 Jun 26, 1996 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
McKesson
Cipla
Julphar
AstraZeneca
QuintilesIMS
Accenture
Covington
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.